Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
D000956:Antigens, Viral / Q000032:analysis; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002051:Burkitt Lymphoma / Q000382:microbiology*; D002455:Cell Division; D002460:Cell Line; D002999:Clone Cells; D003513:Cycloheximide / Q000494:pharmacology*; D004261:DNA Replication / Q000187:drug effects; D004279:DNA, Viral / Q000096:biosynthesis; D004854:Herpesvirus 4, Human / Q000254:growth & development* / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology; D009693:Nucleic Acid Hybridization; D014779:Virus Replication / Q000187:drug effects
D000956:Antigens, Viral; D004279:DNA, Viral; D003513:Cycloheximide; D001973:Bromodeoxyuridine; D007065:Idoxuridine